Transcriptome analysis of non-small cell lung cancer and genetically matched adjacent normal tissues identifies novel prognostic marker genes
暂无分享,去创建一个
J. Choi | Jung-ju Lee | C. Oh | J. Ban | Man-Seok Bang | Yea-jin Lee | Keunsoo Kang
[1] Genevera I. Allen,et al. TCGA2STAT: simple TCGA data access for integrated statistical analysis in R , 2016, Bioinform..
[2] H. Fuchs,et al. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[3] X. Lang,et al. AGER genetic polymorphisms increase risks of breast and lung cancers. , 2015, Genetics and molecular research : GMR.
[4] X. Bian,et al. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types , 2015, Scientific Reports.
[5] Kwok-Kin Wong,et al. Non-small-cell lung cancers: a heterogeneous set of diseases , 2014, Nature Reviews Cancer.
[6] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[7] S. Salzberg,et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.
[8] Chirayu Pankaj Goswami,et al. PROGgeneV2: enhancements on the existing database , 2014, BMC Cancer.
[9] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[10] Jae Cheol Lee,et al. RNA sequencing identifies novel markers of non-small cell lung cancer. , 2014, Lung cancer.
[11] Hong-bing Liu,et al. Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer , 2014, BMC Cancer.
[12] Mary B. Daly,et al. BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer , 2013 .
[13] A. Gazdar,et al. The pivotal role of pathology in the management of lung cancer. , 2013, Journal of thoracic disease.
[14] E. Chen,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[15] John D. Minna,et al. Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations , 2013, Molecular Cancer Research.
[16] Yoo Jin Jung,et al. The transcriptional landscape and mutational profile of lung adenocarcinoma , 2012, Genome research.
[17] Mats Lambe,et al. Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation , 2012, Clinical Cancer Research.
[18] Angela N. Brooks,et al. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.
[19] Kenneth K. Lopiano,et al. RNA-seq: technical variability and sampling , 2011, BMC Genomics.
[20] E. Brambilla,et al. The evolving role of histology in the management of advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Kakajan Komurov,et al. Patterns of human gene expression variance show strong associations with signaling network hierarchy , 2010, BMC Systems Biology.
[22] Hideaki Sugawara,et al. The Sequence Read Archive , 2010, Nucleic Acids Res..
[23] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[24] Sandrine Dudoit,et al. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments , 2010, BMC Bioinformatics.
[25] L. Sequist,et al. Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung Cancer , 2009, Journal of Thoracic Oncology.
[26] Gudrun Schleiermacher,et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma , 2008, Nature.
[27] Brian H. Dunford-Shore,et al. Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.
[28] Timothy B. Stockwell,et al. The Diploid Genome Sequence of an Individual Human , 2007, PLoS biology.
[29] Yi Zhang,et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. , 2006, Cancer research.
[30] David Harrington,et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. , 2002, The New England journal of medicine.
[31] Liquid Biopsies. Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.
[32] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[33] A. Jemal,et al. Global Cancer Statistics , 2011 .
[34] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.